MedTrace Logo

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

NCT03317717 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-03-27

No results posted yet for this study

Summary

This study will determine the pharmacodynamic and safety of MEDITOXIN® in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Meditoxin

injection of MEDITOXIN into EDB muscle of one foot and BOTOX into the same muscle of contralateral foot in equal doses

DRUG

Botox

injection of MEDITOXIN into EDB muscle of one foot and BOTOX into the same muscle of contralateral foot in equal doses

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2018-01-30
Completion
2018-01-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317717 on ClinicalTrials.gov